NUTRACEUTIX INC
SC 13G/A, 2000-02-11
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: CAMERON FINANCIAL CORP /DE/, SC 13G, 2000-02-11
Next: PMI GROUP INC, SC 13G, 2000-02-11



<PAGE>   1

                                                               Page 1 of 4 Pages

                                                   -----------------------------
                                                           OMB APPROVAL
                                                   -----------------------------
                                                   OMB Number:         3235-0145
                                                   Expires:    December 31, 1997
                                                   Estimated average burden
                                                   Hours per response..... 14.90
                                                   -----------------------------

                                  SCHEDULE 13G
                                 (Rule 13d-102)

                    Information to be Included in Statements
           Filed Pursuant to Rule 13d-1(b), (c) and (d) and Amendments
                      Thereto Filed Pursuant to Rule 13d-2

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                               (Amendment No. 1)*


                                Nutraceutix, Inc.
     ----------------------------------------------------------------------
                                (Name of Issuer)


                          Common Stock, $.001 Par Value
     -----------------------------------------------------------------------
                         (Title of Class of Securities)


                                    67060V107
     -----------------------------------------------------------------------
                                 (CUSIP Number)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

                            [ ]    Rule 13d-1 (b)

                            [ ]    Rule 13d-1 (c)

                            [ ]    Rule 13d-1 (d)

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).


<PAGE>   2
- -------------------                                            -----------------
CUSIP NO. 67060V107                SCHEDULE 13G                Page 2 of 4 Pages
- -------------------                                            -----------------

- --------------------------------------------------------------------------------
(1)     NAME OF REPORTING PERSONS/
        I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS(ENTITIES ONLY)
        BRIAN R. JACKSON
- --------------------------------------------------------------------------------
(2)     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                         (a) [ ]
                                                                         (b) [ ]
- --------------------------------------------------------------------------------
(3)     SEC USE ONLY
- --------------------------------------------------------------------------------
(4)     CITIZENSHIP OR PLACE OF ORGANIZATION
        UNITED STATES OF AMERICA
- --------------------------------------------------------------------------------
                              (5)     SOLE VOTING POWER
                                      1,045,000
                              --------------------------------------------------
           NUMBER OF          (6)     SHARED VOTING POWER
             SHARES                   -0-
          BENEFICIALLY        --------------------------------------------------
            OWNED BY          (7)     SOLE DISPOSITIVE POWER
              EACH                    1,045,000
           REPORTING          --------------------------------------------------
          PERSON WITH         (8)     SHARED DISPOSITIVE POWER
                                      -0-
                              --------------------------------------------------

(9)     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
        1,045,000
- --------------------------------------------------------------------------------
(10)    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN
        SHARES*                                                         [ ]
- --------------------------------------------------------------------------------
(11)    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
        6.0%
- --------------------------------------------------------------------------------
(12)    TYPE OF REPORTING PERSON*
        IN
- --------------------------------------------------------------------------------

                     *SEE INSTRUCTIONS BEFORE FILLING OUT.


<PAGE>   3

                                   SCHEDULE 13G                Page 3 of 4 Pages


ITEM 1.
        (a)    Nutraceutix, Inc.
        (b)    8340 154th Avenue N.E., Redmond, Washington  98052
ITEM 2.
        (a)    Brian R. Jackson
        (b)    80 Whitehorn Drive, Miami Springs, FL  33166
        (c)    U.S.A.
        (d)    Common Stock, $.001 Par Value
        (e)    CUSIP # 67060V107

ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b) OR 13d-2(b) OR
        (c), CHECK WHETHER THE PERSON FILING IS A:

        Not Applicable

ITEM 4: OWNERSHIP:

        (a)    1,045,000 shares
        (b)    6.0%
        (c)    (i)    1,045,000 shares
               (ii)   - 0 - shares
               (iii)  1,045,000 shares
               (iv)   - 0 - shares
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:

        Not Applicable

ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:

        Not Applicable


<PAGE>   4

                                   SCHEDULE 13G                Page 4 of 4 Pages


ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
        THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:

        Not Applicable

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:

        Not Applicable

ITEM 9. NOTICE OF DISSOLUTION OF GROUP:

        Not Applicable

ITEM 10. CERTIFICATION:

        "By signing below I certify that, to the best of my knowledge and
        belief, the securities referred to above were not acquired and are not
        held for the purpose of or with the effect of charging or influencing
        the control of the issuer of the securities and were not acquired and
        are not held in connection with or as a participant in any transaction
        having that purpose or effect."

                                      SIGNATURES

        After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

                                                  February 9, 2000
                                                  Date

                                               /S/Brian R. Jackson
                                                  ______________________________
                                                  Brian R. Jackson


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission